Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
12.85
+0.12 (0.94%)
Nov 21, 2024, 4:00 PM EST - Market closed
Pliant Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 782 | 1,085 | 943 | 487 | 806 | - | |
| Market Cap Growth | -34.31% | 15.09% | 93.72% | -39.64% | - | - | |
| Enterprise Value | 430 | 573 | 599 | 265 | 512 | - | |
| Last Close Price | 12.73 | 18.11 | 19.33 | 13.50 | 22.72 | - | |
| PS Ratio | - | 686.53 | 97.32 | 64.25 | 19.28 | - | |
| PB Ratio | 2.24 | 2.29 | 3.01 | 2.44 | 2.85 | - | |
| P/TBV Ratio | 1.97 | 2.29 | 3.01 | 2.44 | 2.85 | - | |
| EV/Sales Ratio | - | 362.78 | 61.84 | 35.06 | 12.25 | - | |
| Debt / Equity Ratio | 0.17 | 0.02 | 0.05 | 0.04 | - | - | |
| Asset Turnover | - | 0.00 | 0.03 | 0.03 | 0.20 | 0.61 | |
| Quick Ratio | 10.18 | 17.43 | 13.98 | 12.06 | 24.71 | 13.48 | |
| Current Ratio | 10.26 | 17.72 | 14.23 | 12.44 | 25.07 | 13.69 | |
| Return on Equity (ROE) | -47.52% | -41.00% | -48.13% | -40.35% | -21.13% | -0.74% | |
| Return on Assets (ROA) | -28.15% | -26.68% | -27.81% | -23.59% | -12.56% | -0.83% | |
| Return on Capital (ROIC) | -30.14% | -28.27% | -29.70% | -24.92% | -13.24% | -0.90% | |
| Earnings Yield | -25.59% | -14.87% | -13.08% | -19.99% | -5.15% | - | |
| FCF Yield | -17.34% | -10.81% | -10.23% | -15.91% | -4.81% | - | |
| Buyback Yield / Dilution | -7.77% | -39.75% | -17.21% | -67.94% | -1214.82% | -39.29% | |
| Total Shareholder Return | -7.77% | -39.75% | -17.21% | -67.94% | -1214.82% | -39.29% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.